A Cdk5–p35 Stable Complex Is Involved in the β-Amyloid-Induced Deregulation of Cdk5 Activity in Hippocampal Neurons
- 1 April 2001
- journal article
- Published by Elsevier BV in Experimental Cell Research
- Vol. 264 (2), 266-274
- https://doi.org/10.1006/excr.2001.5152
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Inhibition of tau phosphorylating protein kinase cdk5 prevents β‐amyloid‐induced neuronal deathFEBS Letters, 1999
- The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau proteinNature, 1999
- Phosphorylation that Detaches Tau Protein from Microtubules (Ser262, Ser214) Also Protects It against Aggregation into Alzheimer Paired Helical FilamentsBiochemistry, 1999
- Evidence for the Participation of the Neuron-Specific CDK5 Activator P35 during Laminin-Enhanced Axonal GrowthJournal of Neuroscience, 1998
- Mice Lacking p35, a Neuronal Specific Activator of Cdk5, Display Cortical Lamination Defects, Seizures, and Adult LethalityNeuron, 1997
- Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.Proceedings of the National Academy of Sciences, 1996
- Role of microtubule-associated proteins in the control of microtubule assemblyPhysiological Reviews, 1995
- Precursor of cdk5 activator, the 23 kDa subunit of tau protein kinase II: Its sequence and developmental change in brainFEBS Letters, 1994
- Tau protein and the neurofibrillary pathology of Alzheimer's diseaseTrends in Neurosciences, 1993
- MAP2 is localized to the dendrites of hippocampal neurons which develop in cultureDevelopmental Brain Research, 1984